Press Release

360Medlink announces the first cancer indication for its TAVIE virtual coach platform.

May 31, 2019

TAVIE is a clinically validated treatment companion app that optimizes patient engagement and treatment adherence. For the past eight years, the TAVIE platform has successfully impacted the lives of people with chronic conditions as evidenced by 90% patient satisfaction, 87% peer referral and a significant increase in adherence. 360Medlink is now releasing TAVIE-cancer, bringing the same value to patients living with oncology conditions.

The TAVIE platform provides interactive, personalized, and evidence-based coaching intervention to improve patient outcomes. The provider portal, TAVIE-PRO facilitates care coordination, remote monitoring, access to real-time data and population health management. Current health care organizations using TAVIE highly value its holistic approach to the patient’s positive care experience and self-efficacy, in addition to care providers enhanced satisfaction.

For additional information on the platform, please visit us at www.360medlink.com or contact us at info@360medlink.com. To contact us for a potential follow up media article, please email jocelynu@360medlink.com

About 360Medlink:

360Medlink is a software company specialized in healthcare. We focus on scientifically tested digital health solutions that bring considerable value to patients, providers and payors. We serve a variety of clients from pharmaceutical/biotech companies, government agencies and healthcare organizations. Our products help improve the lives of patient populations with high unmet needs, such as elderly and vulnerable communities, and from chronic therapies to rare diseases. Through the years we have built unique expertise in healthcare technology and continue to expand strategic partnerships in the international healthcare ecosystem. Today the 360Medlink proprietary platforms serve as catalyst to propel a variety of digital innovations in healthcare.